Nxtcure Labs
Nxtcure Labs is a YC Fall 2026 (F26) company. Based in San Francisco, CA, USA.
About Nxtcure Labs
Summary
Nxtcure Labs runs clinical trials end to end through Galen, a platform of thirteen purpose-built AI agents that handle the routine operational work of a contract research organization, from site feasibility and activation through monitoring, safety reporting, and biostatistics. Every action with clinical, safety, regulatory, or financial consequence is held in a single human review queue and requires approval from a qualified person before it proceeds. The product replaces the manual coordination layer of a traditional CRO while keeping medical and regulatory judgment with certified oncologists and qualified staff.
Business model
Book-a-demo sales process suggests a contracted-service or platform-fee arrangement, though the specific pricing structure is not public.
Go-to-market
Pharmaceutical and biotech sponsors running oncology and other therapeutic trials are the primary buyers, reached through a direct sales motion anchored by a live demo of an active study in the review queue.
From the Y Combinator listing
The full-stack AI CRO for drug discovery.
Reinventing medicine from lab to drug discovery. NxtCure CRO- an AI-native, full-stack CRO built to take therapeutics from discovery to market faster. NxtCure Cancer- the all-in-one mobile platform guiding patients through the cancer journey. We’re building the operating system for the future of medicine.
Facts
- Healthcare / Healthcare -> Therapeutics
- San Francisco, CA, USA
- Active
- Early
Founders (2)
- Keanu Clark
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works